Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lammert

Showing results (1071-1080 of 1,090) with videos related to

Pageof 109
Sort By:
Journal of Autoimmunity|September 11, 2022
SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitisCumali Efe, Koray Taşçılar, Alessio Gerussi, et al.
Gut|February 26, 2021
Hepatobiliary phenotypes of adults with alpha-1 antitrypsin deficiencyMalin Fromme, Carolin V Schneider, Vitor Pereira, et al.
Intestinal Research|August 12, 2024
Bowel movement alterations predict the severity of diverticular disease and the risk of acute diverticulitis: a prospective, international studyAntonio Tursi, Daniele Piovani, Giovanni Brandimarte, et al.
Gastroenterology|May 8, 2020
Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and NoncarriersCarolin V Schneider, Karim Hamesch, Annika Gross, et al.
Gastroenterology|May 24, 2019
Liver Fibrosis and Metabolic Alterations in Adults With alpha-1-antitrypsin Deficiency Caused by the Pi*ZZ MutationKarim Hamesch, Mattias Mandorfer, Vítor M Pereira, et al.
Hepatology (Baltimore, Md.)|October 21, 2019
Genetic Variation in HSD17B13 Reduces the Risk of Developing Cirrhosis and Hepatocellular Carcinoma in Alcohol MisusersFelix Stickel, Philipp Lutz, Stephan Buch, et al.
Hepatology (Baltimore, Md.)|March 13, 2021
Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter StudyCumali Efe, Renumathy Dhanasekaran, Craig Lammert, et al.
The New England Journal of Medicine|August 8, 2022
Germline Mutations in <i>CIDEB</i> and Protection against Liver DiseaseNiek Verweij, Mary E Haas, Jonas B Nielsen, et al.
BMC Public Health|July 19, 2022
LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countriesIsabel Graupera, Maja Thiele, Ann T Ma, et al.
Gut|July 5, 2022
Genetic variation in <i>TERT</i> modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control studyStephan Buch, Hamish Innes, Philipp Ludwig Lutz, et al.
Pageof 109

Showing results (1071-1080 of 1,090) with videos related to

Sort By:
Pageof 109
Journal of Autoimmunity|September 11, 2022
SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitisCumali Efe, Koray Taşçılar, Alessio Gerussi, et al.
Gut|February 26, 2021
Hepatobiliary phenotypes of adults with alpha-1 antitrypsin deficiencyMalin Fromme, Carolin V Schneider, Vitor Pereira, et al.
Intestinal Research|August 12, 2024
Bowel movement alterations predict the severity of diverticular disease and the risk of acute diverticulitis: a prospective, international studyAntonio Tursi, Daniele Piovani, Giovanni Brandimarte, et al.
Gastroenterology|May 8, 2020
Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and NoncarriersCarolin V Schneider, Karim Hamesch, Annika Gross, et al.
Gastroenterology|May 24, 2019
Liver Fibrosis and Metabolic Alterations in Adults With alpha-1-antitrypsin Deficiency Caused by the Pi*ZZ MutationKarim Hamesch, Mattias Mandorfer, Vítor M Pereira, et al.
Hepatology (Baltimore, Md.)|October 21, 2019
Genetic Variation in HSD17B13 Reduces the Risk of Developing Cirrhosis and Hepatocellular Carcinoma in Alcohol MisusersFelix Stickel, Philipp Lutz, Stephan Buch, et al.
Hepatology (Baltimore, Md.)|March 13, 2021
Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter StudyCumali Efe, Renumathy Dhanasekaran, Craig Lammert, et al.
The New England Journal of Medicine|August 8, 2022
Germline Mutations in <i>CIDEB</i> and Protection against Liver DiseaseNiek Verweij, Mary E Haas, Jonas B Nielsen, et al.
BMC Public Health|July 19, 2022
LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countriesIsabel Graupera, Maja Thiele, Ann T Ma, et al.
Gut|July 5, 2022
Genetic variation in <i>TERT</i> modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control studyStephan Buch, Hamish Innes, Philipp Ludwig Lutz, et al.
Pageof 109